DAB486IL-2 data
SRGN published data from separate Phase I trials of DAB486IL-2 in chemotherapy-resistant cancer patients. Data from
Gathering data...
SRGN published data from separate Phase I trials of DAB486IL-2 in chemotherapy-resistant cancer patients. Data from